Vivani Medical
Uždarymo kaina
1.19 0.85
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
1.1400000000000001
Max
1.22
Pajamos | -147K -6.8M |
|---|---|
Darbuotojai | 42 |
Rekomendacijos | Stiprus pirkimas |
|---|---|
12 mėnesių prognozė | +221.85% upside |
Kitas uždarbis | 2026-08-11 |
|---|
Rinkos kapitalizacija | 862K 78M |
|---|---|
Ankstesnė atidarymo kaina | 0.34 |
Ankstesnė uždarymo kaina | 1.19 |
Vivani Medical Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Vivani Medical
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
